Compare OXSQ & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OXSQ | INFU |
|---|---|---|
| Founded | 2003 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.9M | 197.0M |
| IPO Year | 2003 | 2005 |
| Metric | OXSQ | INFU |
|---|---|---|
| Price | $1.40 | $12.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | ★ 1.6M | 162.0K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 22.83% | N/A |
| EPS Growth | N/A | ★ 181.82 |
| EPS | 0.10 | ★ 0.20 |
| Revenue | N/A | ★ $143,436,000.00 |
| Revenue This Year | $3.61 | $3.20 |
| Revenue Next Year | N/A | $7.31 |
| P/E Ratio | ★ $14.20 | $60.95 |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $1.05 | $7.29 |
| 52 Week High | $2.24 | $12.97 |
| Indicator | OXSQ | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 42.22 | 64.02 |
| Support Level | $1.26 | $8.60 |
| Resistance Level | $1.43 | $12.97 |
| Average True Range (ATR) | 0.05 | 0.63 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 13.51 | 79.53 |
Oxford Square Capital Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize portfolio's total return. Its primary current focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and, to a lesser extent collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. CLO investments may also include warehouse facilities, which are early-stage CLO vehicles intended to aggregate loans that may be used to form the basis of a traditional CLO vehicle. The company may also invest in publicly traded debt and/or equity securities.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.